Back to Search
Start Over
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
- Source :
-
British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. e198-e200. Date of Electronic Publication: 2020 Jul 26. - Publication Year :
- 2020
- Subjects :
- Adult
Allografts
Blast Crisis blood
Blast Crisis therapy
COVID-19 blood
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive blood
Leukemia, Myelogenous, Chronic, BCR-ABL Positive therapy
Male
Nitriles
Pyrimidines
Severity of Illness Index
Antibodies, Monoclonal, Humanized administration & dosage
Hematopoietic Stem Cell Transplantation
Pyrazoles administration & dosage
SARS-CoV-2
COVID-19 Drug Treatment
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 190
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 32593183
- Full Text :
- https://doi.org/10.1111/bjh.16979